Status:
UNKNOWN
Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound
Lead Sponsor:
University of Virginia
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Kidney
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if contrast enhanced ultrasound (CEU) using microbubbles, is useful in assessing changes in kidney blood flow.
Eligibility Criteria
Inclusion
- Healthy adults
- Males and females
- Ages 18-65 years old
Exclusion
- Pregnancy or lactation
- H/o kidney disease
- H/o congestive heart failure, ischemic heart disease, severe pulmonary disease or allergy to the drug
- H/o any cardiovascular disease
- Abnormal liver function (liver function tests out of specified ranges)
- Screening urinalysis which indicates infection or inflammation
- Taking regular medications (except for over-the-counter vitamins or hormonal contraceptives.)
- Taking supplements, like protein shakes
- Unwilling or unable to eat chicken (used as protein meal)
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00631553
Start Date
June 1 2006
End Date
December 1 2009
Last Update
August 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia Health System
Charlottesville, Virginia, United States, 22908